Direct infusion of ascites into the blood circuit during hemodiafiltration in uremic patients with cirrhosis

International Journal of Artificial Organs

Volumn 23, Issue 4, 2000, Pages 232-236

  Asakimori, Y ^b   Yorioka, N ^b   Kumagai, J ^b   Kawanishi, H ^a   Tsuchiya, S ^a  

^a TSUCHIYA GENERAL HOSPITAL   (Japan)

^b NONE

Author keywords

Ascites treatment; Chronic maintenance dialysis; Cirrhosis; Hemodiafiltration

Indexed keywords

BLOOD; PATIENT TREATMENT; TIMING CIRCUITS;

ASCITE TREATMENT; ASCITIC FLUIDS; CHRONIC MAINTENANCE DIALYSIS; CIRRHOSIS; CONDITION; DIRECT INFUSIONS; HAEMODYNAMICS; HEMODIAFILTRATION; UREMIC PATIENTS; WEIGHT GAIN;

DIALYSIS;

ADULT; AGED; ARTICLE; ASCITES; ASCITES FLUID; CASE REPORT; HEMODIALYSIS; HEMOFILTRATION; HUMAN; INFUSION; LIVER CIRRHOSIS; MALE; UREMIA;

EID: 0034115102     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880002300404     Document Type: Article

References (12)

1. Parbhoo SP, Ajdukiewicz A, Sherlock S. Treatment of ascites by continuous ultrafiltration and reinfusion of protein concentrate. Lancet 1974; 1: 949-52.
2. Hwang ER, Sherman RA, Mehta S, et al. Dialytic ascitic ultrafiltration in refractory ascites. Am J Gastroenterol 1982; 77: 652-4.
3. Hariprasad MK, Paul PK, Eisenger RB, Gary NE, Timins JE, Miller JW. Extracorporeal dialysis of ascites. A new technique. Arch Intern Med 1981; 141: 1550-1.
4. Marcus RG, Messana J, Swartz R. Peritoneal dialysis in end-stage renal disease patients with preexisting chronic liver disease and ascites. Am J Med 1992; 93: 35-40.
5. Le Veen HH, Wapnick S, Grosberg S, Kinney MJ. Further experience with peritoneo-venous shunt for ascites. Ann Surg 1976; 184: 574-9.
6. Gandhi VC, Leehey DJ, Stanley MM, et al. Peritoneo-venous shunting in patients with cirrhotic ascites and end-stage renal failure. Am J Kidney Dis 1985; 6: 185-7.
7. Gluck Z, Nolph KD. Ascites associated with end-stage renal disease. Am J Kidney Dis 1987; 10: 9-18.
8. Holm A, Rutsky EA, Aldrete JS. Short and long-term effectiveness, morbidity, and mortality of peritoneovenous shunt inserted to treat massive refractory ascites of nephrogenic origin. Analysis of 14 cases. Am Surg 1989; 55: 645-52.
9. Greenberg S, Shapiro WB, Porush JG. Hemodynamic effects of peritoneovenous shunts in hemodialysis patients with ascites. Am J Kidney Dis 1996; 28: 387-94.
10. Greene CH. Physiologic considerations in the treatment of portal cirrhosis. JAMA 1943; 121: 715-20.
11. Vlahcevic ZR, Adham NF, Chalmers TC, et al. Intravenous therapy of massive ascites in patients with cirrhosis. Gastroenterology 1967; 53: 211-9.
12. Catalano C, Fabbian F, Landro DD. Reinfusion and concentration of ascitic fluid during hemodialysis in a cirrhotic uremiC patient. Am J Kidney Dis 1998; 32: 164-7.